Jim Simons Dr Reddys Laboratories LTD Call Options Transaction History
Renaissance Technologies LLC
- $56.7 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RDY
# of Institutions
233Shares Held
24MCall Options Held
14.6KPut Options Held
2.8K-
Robeco Institutional Asset Management B.V.2.07MShares$153 Million0.33% of portfolio
-
Royal Bank Of Canada Toronto, A62.06MShares$152 Million0.04% of portfolio
-
Morgan Stanley New York, NY2.03MShares$151 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$134 Million0.0% of portfolio
-
Aikya Investment Management LTD London, X01.39MShares$103 Million30.55% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $12.3B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...